NeoGenomics, Inc. (NEO)
 NASDAQ: NEO · Real-Time Price · USD
 9.78
 +0.01 (0.10%)
  At close: Nov 3, 2025, 4:00 PM EST
9.78
 0.00 (0.00%)
  After-hours: Nov 3, 2025, 6:59 PM EST
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees 
 2,200
Change (1Y) 
 100
Growth (1Y) 
 4.76%
Revenue / Employee 
 $322,346
Profits / Employee 
 -$51,576
Market Cap 
1.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 2,200 | 100 | 4.76% | 
| Dec 31, 2023 | 2,100 | 0 | - | 
| Dec 31, 2022 | 2,100 | 100 | 5.00% | 
| Dec 31, 2021 | 2,000 | 300 | 17.65% | 
| Dec 31, 2020 | 1,700 | 0 | - | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
NEO News
- 4 days ago - NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors - Business Wire
 - 6 days ago - NeoGenomics, Inc. (NEO) Q3 2025 Earnings Call Transcript - Seeking Alpha
 - 6 days ago - NeoGenomics Reports Third Quarter 2025 Results - Business Wire
 - 20 days ago - NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 - Business Wire
 - 27 days ago - NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 - Business Wire
 - 6 weeks ago - NeoGenomics Stock In A Range-Bound Matrix, Weakness Likely Until 2026 - Benzinga
 - 2 months ago - NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims - Benzinga
 - 2 months ago - Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera - Business Wire